Total Payments
$1,635
2024 Payments
$112.73
Companies
9
Transactions
56
Medicare Patients
1,747
Medicare Billing
$204,727
Payment Breakdown by Category
Food & Beverage$1,635 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,635 | 56 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,045 | 26 | $0 (2024) |
| Boston Scientific Corporation | $391.85 | 21 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63.07 | 3 | $0 (2024) |
| Nevro Corp. | $41.94 | 1 | $0 (2022) |
| Fidia Pharma USA Inc. | $24.92 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.98 | 1 | $0 (2022) |
| Azurity Pharmaceuticals, Inc. | $20.03 | 1 | $0 (2023) |
| Lilly USA, LLC | $14.91 | 1 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $11.42 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.73 | 5 | Medtronic, Inc. ($71.37) |
| 2023 | $406.91 | 15 | Medtronic, Inc. ($247.05) |
| 2022 | $1,033 | 34 | Medtronic, Inc. ($656.02) |
| 2021 | $82.39 | 2 | Medtronic, Inc. ($70.97) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $41.26 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Gastroenterology | ||||||
| 04/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Gastroenterology | ||||||
| 12/01/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $47.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/28/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Sleep | ||||||
| 11/08/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/19/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $53.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/10/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Gastroenterology | ||||||
| 04/26/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $83.07 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: General - Therapies_NMD | ||||||
| 02/23/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/22/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/20/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/13/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neuroscience | ||||||
| 01/18/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 01/11/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 01/09/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $36.54 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/16/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $46.11 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/28/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/28/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/09/2022 | Boston Scientific Corporation | General - Therapies (Device) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: General - Therapies_NMD | ||||||
| 10/19/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 884 | 1,659 | $340,490 | $98,813 |
| 2022 | 22 | 863 | 1,629 | $358,931 | $105,914 |
Total Patients
1,747
Total Services
3,288
Medicare Billing
$204,727
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 34 | 38 | $52,450 | $17,339 | 33.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 57 | 64 | $59,220 | $13,694 | 23.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 39 | 59 | $43,700 | $10,553 | 24.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 50 | 59 | $26,786 | $10,506 | 39.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 33 | 40 | $26,280 | $9,464 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 66 | $13,200 | $6,007 | 45.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 39 | 59 | $22,540 | $5,911 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $14,122 | $5,484 | 38.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 21 | 21 | $10,920 | $3,928 | 36.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 21 | 23 | $24,800 | $2,888 | 11.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 26 | 32 | $13,440 | $2,679 | 19.9% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 27 | 31 | $5,425 | $2,618 | 48.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 40 | 46 | $9,798 | $1,713 | 17.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 25 | 26 | $3,120 | $1,583 | 50.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 29 | $6,265 | $1,430 | 22.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 105 | 136 | $1,910 | $1,260 | 65.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 11 | 11 | $2,750 | $1,234 | 44.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 40 | 49 | $370.00 | $263.83 | 71.3% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 15 | 18 | $1,620 | $144.53 | 8.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 57 | 644 | $1,288 | $61.43 | 4.8% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 120 | 162 | $486.00 | $54.55 | 11.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 31 | 33 | $45,200 | $16,340 | 36.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 47 | 71 | $53,960 | $14,259 | 26.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 49 | 57 | $57,330 | $13,492 | 23.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 30 | 36 | $23,760 | $9,104 | 38.3% |
About Simranjit Singh
Simranjit Singh is a Interventional Pain Medicine healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1922462639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Simranjit Singh has received a total of $1,635 in payments from pharmaceutical and medical device companies, with $112.73 received in 2024. These payments were reported across 56 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,635).
As a Medicare-enrolled provider, Singh has provided services to 1,747 Medicare beneficiaries, totaling 3,288 services with total Medicare billing of $204,727. Data is available for 2 years (2022–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Anesthesiology, Pain Medicine
- Location Fayetteville, NC
- Active Since 04/08/2016
- Last Updated 10/15/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1922462639
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $933.24
- WaveWriter Alpha Prime 16 (Device) $352.78
- VECTRIS (Device) $70.97
- RELISTOR (Drug) $63.07
- Omnia (Device) $41.94
- VECTRIS SURESCAN (Device) $41.20
- HYMOVIS (Device) $24.92
- General - Therapies (Device) $24.84
- NURTEC ODT (Drug) $20.98
- Horizant (Drug) $20.03
- EMGALITY (Drug) $14.91
- BELBUCA (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.